Thomas Krueger

Title: Thomas Krueger: Innovator in Medicinal Chemistry

Introduction

Thomas Krueger is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for neuropathic problems. His innovative approach has led to advancements in the use of morphine derivatives as effective medicaments.

Latest Patents

Thomas Krueger holds a patent for the "Use of morphine derivatives as medicaments for the treatment of neuropathic problems." This patent outlines a method for agonizing or antagonizing the ORL1 (opioid receptor-like) receptor of the nociceptin/orphanin FQ ligand ORL1 receptor system using a morphinan compound of the general formula I or derivatives thereof. The patent also discloses methods for treating various conditions, including neuropathic pain, anxiety, depression, urinary incontinence, and cognitive dysfunctions, among others. He has 1 patent to his name.

Career Highlights

Throughout his career, Thomas has been associated with Gruenenthal GmbH, a company known for its focus on pain management and innovative pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of complex medical conditions.

Collaborations

Thomas Krueger has collaborated with esteemed colleagues, including Wolfgang Werner Strassburger and Helmut Heinrich Buschmann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Thomas Krueger's contributions to medicinal chemistry and his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to impact the treatment of neuropathic problems and related conditions.